113 related articles for article (PubMed ID: 9030896)
1. GW1229, a novel neuropeptide Y Y1 receptor antagonist, inhibits the vasoconstrictor effect on neuropeptide Y in the hamster microcirculation.
Bitran M; Daniels AJ; Boric MP
Eur J Pharmacol; 1997 Jan; 319(1):43-7. PubMed ID: 9030896
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y is a vasoconstrictor and adrenergic modulator in the hamster microcirculation by acting on neuropeptide Y1 and Y2 receptors.
Boric MP; Martinez A; Donoso MV; Huidobro-Toro JP
Eur J Pharmacol; 1995 Dec; 294(2-3):391-401. PubMed ID: 8750699
[TBL] [Abstract][Full Text] [Related]
3. Novel neuropeptide Y receptor antagonists block vasoconstriction in the hamster cheek pouch microcirculation.
Kim D; Durán WT; Daniels AJ; Durán WN
Microvasc Res; 1997 Mar; 53(2):167-72. PubMed ID: 9143549
[TBL] [Abstract][Full Text] [Related]
4. Microcirculatory dynamics of neuropeptide Y.
Kim D; Durán WR; Kobayashi I; Daniels AJ; Durán WN
Microvasc Res; 1994 Jul; 48(1):124-34. PubMed ID: 7990718
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y induced inhibition of noradrenaline release in rat hypothalamus: role of receptor subtype and nitric oxide.
Bitran M; Tapia W; Eugenín E; Orio P; Boric MP
Brain Res; 1999 Dec; 851(1-2):87-93. PubMed ID: 10642831
[TBL] [Abstract][Full Text] [Related]
7. SR 120107A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo.
Malmström RE; Modin A; Lundberg JM
Eur J Pharmacol; 1996 Jun; 305(1-3):145-54. PubMed ID: 8813545
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
Oellerich WF; Malik KU
J Pharmacol Exp Ther; 1993 Sep; 266(3):1321-9. PubMed ID: 8371140
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
Ralevic V; Edvinsson L; Burnstock G
Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
[TBL] [Abstract][Full Text] [Related]
10. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
Han S; Yang CL; Chen X; Naes L; Cox BF; Westfall T
Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
[TBL] [Abstract][Full Text] [Related]
12. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.
Abounader R; Villemure JG; Hamel E
Br J Pharmacol; 1995 Oct; 116(4):2245-50. PubMed ID: 8564255
[TBL] [Abstract][Full Text] [Related]
13. Activation of thromboxane receptors and the induction of vasomotion in the hamster cheek pouch microcirculation.
Verbeuren TJ; Vallez MO; Lavielle G; Bouskela E
Br J Pharmacol; 1997 Nov; 122(5):859-66. PubMed ID: 9384501
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivo.
Malmström RE; Balmér KC; Weilitz J; Nordlander M; Sjölander M
Eur J Pharmacol; 2001 Apr; 418(1-2):95-104. PubMed ID: 11334870
[TBL] [Abstract][Full Text] [Related]
15. GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists.
Parker EM; Babij CK; Balasubramaniam A; Burrier RE; Guzzi M; Hamud F; Mukhopadhyay G; Rudinski MS; Tao Z; Tice M; Xia L; Mullins DE; Salisbury BG
Eur J Pharmacol; 1998 May; 349(1):97-105. PubMed ID: 9669502
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435.
Malmstrom RE; Lundberg JM
Eur J Pharmacol; 1995 Dec; 294(2-3):661-8. PubMed ID: 8750731
[TBL] [Abstract][Full Text] [Related]
17. Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub-types on arterioles of the guinea-pig small intestine and the rat brain.
Xia J; Neild TO; Kotecha N
Br J Pharmacol; 1992 Nov; 107(3):771-6. PubMed ID: 1472974
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction.
Dubinion JH; Mi Z; Zhu C; Gao L; Jackson EK
Hypertension; 2006 Mar; 47(3):545-51. PubMed ID: 16365188
[TBL] [Abstract][Full Text] [Related]
19. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
J Pharmacol Exp Ther; 1993 Apr; 265(1):172-7. PubMed ID: 8474004
[TBL] [Abstract][Full Text] [Related]
20. In vivo characterization of the novel neuropeptide Y Y1 receptor antagonist H 409/22.
Malmström RE; Alexandersson A; Balmér KC; Weilitz J
J Cardiovasc Pharmacol; 2000 Oct; 36(4):516-25. PubMed ID: 11026655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
